Herbas VPB

Print
EN | LT
LT - Žmogaus antikūnai prieš PCSK9, skirti naudoti konkrečių individų grupių gydymo būduose
EN - HUMAN ANTIBODIES TO PCSK9 FOR USE IN METHODS OF TREATING PARTICULAR GROUPS OF SUBJECTS

Legal status

Patent in force

Bibliographic data
Indications of the International Patent Classification (IPC)
(51) INT.CL. C07K 16/40 (2006.01)
A61K 39/00 (2006.01)
A61K 39/395 (2006.01)
A61K 45/06 (2006.01)
A61J 1/05 (2006.01)
A61K 31/215 (2006.01)
A61K 31/366 (2006.01)
A61K 31/404 (2006.01)
A61K 31/435 (2006.01)
A61K 31/47 (2006.01)
A61K 31/505 (2006.01)
A61K 31/395 (2006.01)
C07K 14/47 (2006.01)
European patent
(11) Number of the document 2668212
(13) Kind of document T
(96) European patent application number 12701742.4
Date of filing the European patent application 2012-01-27
(97) Date of publication of the European application 2013-12-04
(45) Date of publication and mention of the grant of the patent 2018-03-21
(46) Date of publication of the claims translation 2018-07-10
PCT application
(86) Number PCT/EP2012/051320
Date 2012-01-27
PCT application publication
(87) Number WO 2012/101252
Date 2012-08-02
Priority applications
(30) Number Date Country code
11305088 2011-01-28 EP
11305089 2011-01-28 EP
11305513 2011-04-29 EP
11305514 2011-04-29 EP
11306039 2011-08-12 EP
11306040 2011-08-12 EP
11306201 2011-09-22 EP
11306202 2011-09-22 EP
11306449 2011-11-08 EP
11306450 2011-11-08 EP
Inventors
(72)
HANOTIN, Corinne, FR
BESSAC, Laurence, FR
CHAUDHARI, Umesh, US
Grantee
(73) Sanofi Biotechnology, 54 rue La Boétie, 75008 Paris, FR
Attorney or representative
(74) Liudmila GERASIMOVIČ, IĮ "Liudmila Gerasimovič, Patentinis patikėtinis", Vingrių g. 13-42, LT-01141 Vilnius, LT
Title
(54) Žmogaus antikūnai prieš PCSK9, skirti naudoti konkrečių individų grupių gydymo būduose
  HUMAN ANTIBODIES TO PCSK9 FOR USE IN METHODS OF TREATING PARTICULAR GROUPS OF SUBJECTS
Last renewal fee
Payment date Validity (years) Amount
2025-12-18 15 289.00 EUR
Next renewal fee
2027-01-27